A study published this week by the journal PLoS One, and published online by the National Institute of Health, has found that cannabis may provide a treatment option for obstructive sleep apnea (OSA).
For the study, researchers at the University of Illinois took rats with a form of sleep apnea and injected them with cannabis receptor antagonists (meant to mimic the effect of cannabinoids), as well as THC (tetrahydrocannabinol).
According to researchers; “These findings underscore the therapeutic potential of dronabinol [THC] in the treatment of OSA and implicate participation of both cannabinoid receptors in dronabinol’s apnea suppression effect.”
According to researchers, 9% of Americans experience obstructive sleep apnea, with that number on the rise.
The results of this study echo the findings of a study published last October in the journal Respiratory Physiology & Neurobiology, which concludes; “These findings underscore a therapeutic potential of dronabinol for the treatment of obstructive sleep apnea.”